tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO

Compare Crescent Biopharma (CBIO) vs. Competitors

Compare
997 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crescent Biopharma
$10.97
$302.30M
-0.50
-60.37%
6 Buy
0 Hold
0 Sell
Strong Buy
Compugen
$1.64
$153.40M
-5.48
3.14%
3 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$1.06
$122.27M
-0.80
-36.53%
5 Buy
4 Hold
0 Sell
Moderate Buy
Orchestra BioMed Holdings
$4.84
$273.29M
-2.66
-9.87%
4 Buy
0 Hold
0 Sell
Strong Buy
Fractyl Health, Inc.
$2.10
$287.79M
-0.92
10.53%
4 Buy
0 Hold
0 Sell
Strong Buy
Actuate Therapeutics, Inc.
$6.28
$145.97M
-5.19
-21.50%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CBIO
Crescent Biopharma
10.97
-14.12
-56.28%
CGEN
Compugen
1.64
-0.35
-17.59%
FATE
Fate Therapeutics
1.06
-0.23
-17.83%
OBIO
Orchestra BioMed Holdings
4.84
-0.29
-5.65%
GUTS
Fractyl Health, Inc.
2.10
0.15
7.69%
ACTU
Actuate Therapeutics, Inc.
6.28
-1.80
-22.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts